* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Nucline RNA and Its Uses
Transcriptional regulation wikipedia , lookup
Gene expression profiling wikipedia , lookup
Secreted frizzled-related protein 1 wikipedia , lookup
Gene regulatory network wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
RNA interference wikipedia , lookup
Cell-penetrating peptide wikipedia , lookup
Polyadenylation wikipedia , lookup
RNA silencing wikipedia , lookup
Endogenous retrovirus wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Silencer (genetics) wikipedia , lookup
List of types of proteins wikipedia , lookup
Non-coding RNA wikipedia , lookup
Gene expression wikipedia , lookup
Nucline RNA SunPillar, LLC ©C. Allen Black; SunPillar, LLC 2002 What is Nucline? • Nucline is a full length mRNA molecule. • It is conditionally translated into a protein. • Protein is only expressed when researcher-defined gene profiles are present in the cell. • It can be used to modify, tag, and even destroy cells that express the gene profile. • It is not siRNA (methylates target DNA) or antisense (blocks mRNA translation.) These only “turn off”/”turn down” protein expression. ©C. Allen Black; SunPillar, LLC mRNA translation • 30s ribosome subunit binds the 5’ cap. • It scans through the mRNA sequence. • It stalls at the AUG start condon, binds the 50s subunit and beings translating the protein. • The 5’ Untranslated Region (UTR) upstream of the start codon regulates scanning and initiation. translation begins 30s 5' scan UTR 50s 30s AUG protein sequence ©C. Allen Black; SunPillar, LLC 3' mRNA can be “blocked” by 5’ UTR secondary structure • The ribosome requires energy to scan through the UTR. • A mRNA with strong secondary structure prevents the ribosome from ever reaching the AUG codon. The ribosome cannot melt the structure. • E.g. Antisense, stem-loops, and hairpins impede the ribosome and prevent translation. scan 30s 5' stal l AUG protein sequence ©C. Allen Black; SunPillar, LLC 3' Nucline: designing a “drug” by example • Pick a disease: B cell lymphoma • Pick what gene you wish the target cell to express: pertussis toxin (suicide gene) • Pick sequences (normal or mutant) that are only expressed in B cell lymphoma (mutant c-myc and IgM) • Insert construct into an mRNA transcription vector, runoff mRNA, and ligate repressors. • Deliver mRNA via liposomes, virosomes, ballistic penetration, electroporation etc. ©C. Allen Black; SunPillar, LLC Step 1: the protein • Construct suicide gene. • AUG placed upstream of pertussis toxin. • All transfected cells will die. mRNA permanently “on.” No secondary structure. 50s translation 30s 5' AUG Pertussis Toxin ©C. Allen Black; SunPillar, LLC 3' Step 2: the 5’UTR • Place sense sequences (100bp) corresponding to cmyc and IgM in the 5’UTR. • All transfected cells will die. mRNA permanently “on.” No secondary structure present. 50s 30s 5' scan IgM 30s c-myc AUG translation pertussis toxin ©C. Allen Black; SunPillar, LLC 3' Step 3: Ligate antisense • Add anti- sense sequences (100 bp) complementary to IgM and c-myc in the 5’UTR. IgM 5' IgM c-myc c-myc AUG pertussis toxin ©C. Allen Black; SunPillar, LLC 3' Nucline in normal cells In IgM-, c-myc- cells, antisense stays “stuck” to Nucline. The antisense has only Nucline coded sense sequences to bind. No translation in normal cells. 30s stall 5' IgM IgM c-myc c-myc AUG ©C. Allen Black; SunPillar, LLC pertussis toxin 3' Nucline in normal B cells. • Anti-sense will hybridize to its complements. • In normal B cells (non-c-myc cells), IgM wt mRNA competes off the antisense. The antisense “choses” between binding Nucline or wt IgM RNA. Both have sense sequences so competitive hybridization occurs. • The c-myc antisense stays “stuck” to Nucline. Still, no translation. Half of secondary structure still present. IgM stall 30s 5' IgM wild type IgM mRNA IgM AUG c-myc c-myc AUG pertussis toxin ©C. Allen Black; SunPillar, LLC 3' Nucline in B cell lymphoma. • Anti-sense will hybridize to its complements. • IgM wt mRNA competes off the IgM antisense. • c-myc wt RNA competes off the c-myc antisense. TRANSLATION. All of secondary structure removed. AUG c-myc 30s 5' scan IgM c-myc 50s wild type c-myc mRNA translation 30s c-myc AUG pertussis toxin ©C. Allen Black; SunPillar, LLC 3' But this is biology, will it really work? ©C. Allen Black; SunPillar, LLC Detecting Estrogen Receptor Overexpression • • • • • • Using the plasmid provided the GFP along with the ER regions was amplified using the two primers Nucln FP and Nucln RP. RNA was synthesized using this PCR DNA and Ribomax kit from Promega. MCF-7 cells were purchased from ATCC and were grown in RPMI medium with 10% fetal calf serum. For transfection 1 ug RNA was mixed 1ug of Nucline and boiled for 10 min and allowed to hybridize. To this 2 ul of Tfx-50 reagent (Promega) was added and incubated for 10 min with 300 ul serum free medium. This was added to MCF-7 cells, after washing the monolayer with RPMI without serum. The cell density was about 60 to 70%. Transfection was allowed for 30 min after which the medium was removed and replaced by serum containing medium. The cells were observed under microscope after 24 hrs post-transfection ER Target Sequence: 5’ ggtcacgtggtaactatttggtcacgtggtaactattt Special Thanks to Dr. Augustine Rajakumar (University of Pittsburgh) and Dr. Yunus Luqmani (Kuwait University) for providing these Estrogen Receptor data. ©C. Allen Black; SunPillar, LLC MCF-7 Cells (Bright Field) ©C. Allen Black; SunPillar, LLC MCF-7 Positive Control GFP Plasmid ©C. Allen Black; SunPillar, LLC Nucline Transfection Specific for Estrogen Receptor Overexpression ©C. Allen Black; SunPillar, LLC Repeated Again ©C. Allen Black; SunPillar, LLC What about in vivo? • Mouse solid tumor model (MM2MT breast carcinoma). DeFatta, RJ, Li, Y., De Bendetti, Cancer Gene Therapy 9:503 (2002). • Introduced RNA with impenetrable 5’ UTR (hairpins). RNA coded suicide gene. • DNA coding the RNA was lipofected into animals. • eIF4E (cap binding protein) over expressed in tumor, not regular cells. It “melts” RNA structure in cancer but not normal cells. 120 day survival: 0/10 control; 7/10 experimental. 70% cure rate. ©C. Allen Black; SunPillar, LLC Curing Cancer (in mice) • DeFatta et al. used “protein assisted” melting. • Nucline uses “sequence assisted” competitive hybridization to melt secondary structure. • Nucline is sequence specific, eIF4E melts any secondary structure. • Mode of melting irrelevant for biological effect • RNA with de-repressible secondary structure (confering specificity) cures cancer in mice. Nucline design increases the utility and specificity. ©C. Allen Black; SunPillar, LLC Uses • FACS (deliver fluorescent protein) • (+)/(-) cell selection (suicide/proliferation inducing genes) • Disease models (suicide genes, repair genes) • Wound repair/gene defects (deliver proliferation inducing genes or new “correct” gene) • Detect mRNA/(s)tructural RNA profiles, mRNA/sRNA concentration, mRNA/sRNA sequences. ©C. Allen Black; SunPillar, LLC Nucline Logic • It is a logic system where A,B are cellular mRNA sequences and Y is a protein to be expressed in those cells alone. • IF A is present, THEN release Y. (One antisense blocking translation) • IF A and B are present, THEN release Y. (different antisense targets on same Nucline RNA, e.g. lymphoma Nucline) • IF A or B is present, THEN release Y. (Combine two different kinds of Nucline molecules) • IF A is present > 100 copies, THEN release Y. (Nucline with 101 redundant antisense stuck to it) • IF A but not B present, THEN release Y. (advancing) • IF A present < 100 copies, THEN release Y. (advancing) ©C. Allen Black; SunPillar, LLC WWW.SUNPILLAR.COM [email protected] ©C. Allen Black; SunPillar, LLC